Octagos Health, a Houston, TX-based provider of AI-driven cardiac device monitoring solutions, raised over $43M in Series B funding.
The round was led by Morgan Stanley Expansion Capital, with participation from Mucker Capital and other strategic investors.
The company intends to use the funds to accelerate enhancements to its platform, in addition to scaling its commercial team and operations.
Led by CEO Dr. Shanti Bansal, Octagos Health is a provider of cardiac monitoring solutions, dedicated to improving patient outcomes through technology and comprehensive monitoring services. Its AI-driven platform offers continuous monitoring and data analysis for patients with implantable cardiac devices, enabling healthcare providers to make informed decisions and deliver timely care. Octagos Health’s solutions are designed to integrate with electronic health records and provide customizable reporting features, making it an essential tool for modern healthcare institutions.
